Ursodeoxycholic Acid, Sodium Salt is a steroid and secondary bile acid formed via epimerization of chenodeoxycholic acid. Ursodeoxycholic Acid, Sodium Salt reduces hydrophobic bile acids. Ursodeoxycholic Acid, Sodium Salt also decreases lymphocyte reactivity and serum alkaline phosphatase levels when used in the treatment for primary biliary cirrhosis. Ursodeoxycholic Acid, Sodium Salt is also known as UDCA, Sodium Ursodeoxycholate, and (5β)-3α,7β-dihydroxy-cholan-24-oic acid, monosodium salt.
1. Oh, A.R. et al. 2016. BMB Rep. 49(2): 105-110. PMID: 26350747
See how others have used Ursodeoxycholic Acid, Sodium Salt (CAS 2898-95-5). Click on the entry to view the PubMed entry .
PMID: # 30767682 2019. Am. J. Physiol. Gastrointest. Liver Physiol. 316: G574-G584.
PMID: # 29351391 Mroz, MS.|Lajczak, NK.|Goggins, BJ.|Keely, S.|Keely, SJ.| et al. 2018. Am. J. Physiol. Gastrointest. Liver Physiol. 314: G378-G387.
PMID: # 26351365 Sousa, T. et al. 2015. Journal of lipid research. 56: 2158-71.
PMID: # 27402811 J Mol Cell Biol. 530-541.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.